Maat Pharma SA (MAAT) — Financial Flexibility Index
Maat Pharma SA (MAAT) has a Financial Flexibility Index of -0.37x as of June 2025. Free cash flow of €-15.17 Million (operating CF €-15.37 Million minus capex €202.00K) represents 0% of total liabilities (€40.58 Million). Check Maat Pharma SA (MAAT) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Maat Pharma SA Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Maat Pharma SA across 8 annual periods. For the full cash flow conversion analysis, see Maat Pharma SA (MAAT) cash conversion ratio.
Annual Financial Flexibility Index for Maat Pharma SA (2017–2024)
Year-by-year free cash flow to debt coverage for Maat Pharma SA. Explore MAAT operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.76x | €-21.29 Million | €-22.04 Million | €28.16 Million | ▲ +3.4% |
| 2023 | -0.78x | €-17.58 Million | €-18.67 Million | €22.46 Million | ▼ -17.4% |
| 2022 | -0.67x | €-11.94 Million | €-12.61 Million | €17.91 Million | ▲ +17.1% |
| 2021 | -0.80x | €-7.69 Million | €-7.93 Million | €9.56 Million | ▼ -22.0% |
| 2020 | -0.66x | €-5.50 Million | €-5.81 Million | €8.34 Million | ▼ -71.7% |
| 2019 | -0.38x | €-4.89 Million | €-5.02 Million | €12.73 Million | ▲ +50.5% |
| 2018 | -0.78x | €-3.58 Million | €-3.87 Million | €4.62 Million | ▲ +13.5% |
| 2017 | -0.90x | €-3.58 Million | €-3.87 Million | €3.99 Million | — |